Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial (Q44404507)

2 December 2017

title

Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial (English)

1 reference

2 December 2017

main subject

irritable bowel syndrome

1 reference

Gabriele Moser

1

1 reference

2 December 2017

Silja Trägner

2

1 reference

2 December 2017

Ewelina Elwira Gajowniczek

3

1 reference

2 December 2017

Andrea Mikulits

4

1 reference

2 December 2017

Maria Michalski

5

1 reference

2 December 2017

Lili Kazemi-Shirazi

6

1 reference

2 December 2017

Stefanie Kulnigg-Dabsch

7

1 reference

2 December 2017

Martina Führer

8

1 reference

2 December 2017

Elisabeth Ponocny-Seliger

9

1 reference

2 December 2017

Clemens Dejaco

10

1 reference

2 December 2017

Wolfgang Miehsler

11

1 reference

2 December 2017

language of work or name

English

0 references

publication date

19 February 2013

1 reference

The American Journal of Gastroenterology

2 December 2017

published in

1 reference

2 December 2017

volume

108

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

602-609

1 reference

The functional gastrointestinal disorders and the Rome III process

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Clinical practice. Irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Functional GI disorders: from animal models to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Hypnotherapy in severe irritable bowel syndrome: further experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Long term benefits of hypnotherapy for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Mo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.19

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.19

1 reference

2 December 2017

1 reference